These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 28130063)

  • 1. Effects of control interventions on Clostridium difficile infection in England: an observational study.
    Dingle KE; Didelot X; Quan TP; Eyre DW; Stoesser N; Golubchik T; Harding RM; Wilson DJ; Griffiths D; Vaughan A; Finney JM; Wyllie DH; Oakley SJ; Fawley WN; Freeman J; Morris K; Martin J; Howard P; Gorbach S; Goldstein EJC; Citron DM; Hopkins S; Hope R; Johnson AP; Wilcox MH; Peto TEA; Walker AS; Crook DW;
    Lancet Infect Dis; 2017 Apr; 17(4):411-421. PubMed ID: 28130063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse sources of C. difficile infection identified on whole-genome sequencing.
    Eyre DW; Cule ML; Wilson DJ; Griffiths D; Vaughan A; O'Connor L; Ip CLC; Golubchik T; Batty EM; Finney JM; Wyllie DH; Didelot X; Piazza P; Bowden R; Dingle KE; Harding RM; Crook DW; Wilcox MH; Peto TEA; Walker AS
    N Engl J Med; 2013 Sep; 369(13):1195-205. PubMed ID: 24066741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A global to local genomics analysis of Clostridioides difficile ST1/RT027 identifies cryptic transmission events in a northern Arizona healthcare network.
    Williamson CHD; Stone NE; Nunnally AE; Hornstra HM; Wagner DM; Roe CC; Vazquez AJ; Nandurkar N; Vinocur J; Terriquez J; Gillece J; Travis J; Lemmer D; Keim P; Sahl JW
    Microb Genom; 2019 Jul; 5(7):. PubMed ID: 31107202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile.
    Dingle KE; Freeman J; Didelot X; Quan TP; Eyre DW; Swann J; Spittal WD; Clark EV; Jolley KA; Walker AS; Wilcox MH; Crook DW
    mBio; 2023 Apr; 14(2):e0024323. PubMed ID: 37017518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of
    Wieczorkiewicz JT; Skinner AM; Cheknis A; Petrella LA; Stevens VW; Wright LM; Gerding DN; Johnson S
    Antimicrob Agents Chemother; 2024 Aug; 68(8):e0069824. PubMed ID: 38953622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018-2019.
    Plankaova A; Brajerova M; Capek V; Balikova Novotna G; Kinross P; Skalova J; Soltesova A; Drevinek P; Krutova M
    Int J Antimicrob Agents; 2023 Jul; 62(1):106824. PubMed ID: 37116667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dogs as carriers of virulent and resistant genotypes of Clostridioides difficile.
    Finsterwalder SK; Loncaric I; Cabal A; Szostak MP; Barf LM; Marz M; Allerberger F; Burgener IA; Tichy A; Feßler AT; Schwarz S; Monecke S; Ehricht R; Ruppitsch W; Spergser J; Künzel F
    Zoonoses Public Health; 2022 Sep; 69(6):673-681. PubMed ID: 35546073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing.
    Eyre DW; Fawley WN; Rajgopal A; Settle C; Mortimer K; Goldenberg SD; Dawson S; Crook DW; Peto TEA; Walker AS; Wilcox MH
    Clin Infect Dis; 2017 Aug; 65(3):433-441. PubMed ID: 28575285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence.
    Kumar N; Miyajima F; He M; Roberts P; Swale A; Ellison L; Pickard D; Smith G; Molyneux R; Dougan G; Parkhill J; Wren BW; Parry CM; Pirmohamed M; Lawley TD
    Clin Infect Dis; 2016 Mar; 62(6):746-752. PubMed ID: 26683317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated
    Dingle KE; Didelot X; Quan TP; Eyre DW; Stoesser N; Marwick CA; Coia J; Brown D; Buchanan S; Ijaz UZ; Goswami C; Douce G; Fawley WN; Wilcox MH; Peto TEA; Walker AS; Crook DW
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of Clostridioides difficile ribotype 027 in a major Chinese hospital.
    Zhang RF; Man YX; Bai YY; Shao CH; Liu CM; Wang CH; Lei YX; Wang Y; Jin Y
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1179-1183. PubMed ID: 33563561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones.
    Walbrown MA; Aspinall SL; Bayliss NK; Stone RA; Cunningham F; Squier CL; Good CB
    J Manag Care Pharm; 2008; 14(1):34-40. PubMed ID: 18240880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
    Curry SR; Muto CA; Schlackman JL; Pasculle AW; Shutt KA; Marsh JW; Harrison LH
    Clin Infect Dis; 2013 Oct; 57(8):1094-102. PubMed ID: 23881150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of syndrome-specific antimicrobial stewardship interventions on use of and resistance to fluoroquinolones: An interrupted time series analysis.
    Hecker MT; Son AH; Murphy NN; Sethi AK; Wilson BM; Watkins RR; Donskey CJ
    Am J Infect Control; 2019 Aug; 47(8):869-875. PubMed ID: 30850252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of Clostridium difficile strains from nosocomial-acquired infections.
    Corbellini S; Piccinelli G; De Francesco MA; Ravizzola G; Bonfanti C
    Folia Microbiol (Praha); 2014 Mar; 59(2):173-9. PubMed ID: 24081935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multisite genomic epidemiology study of
    Miles-Jay A; Young VB; Pamer EG; Savidge TC; Kamboj M; Garey KW; Snitkin ES
    Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34180789
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic resistance of clinical isolates of Clostridioides difficile in China and its association with geographical regions and patient age.
    Li H; Li WG; Zhang WZ; Yu SB; Liu ZJ; Zhang X; Wu Y; Lu JX
    Anaerobe; 2019 Dec; 60():102094. PubMed ID: 31499177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020-2022.
    Schwartz O; Rohana H; Azrad M; Shor A; Rainy N; Maor Y; Nesher L; Sagi O; Peretz A
    Sci Rep; 2024 Sep; 14(1):20607. PubMed ID: 39232075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.